Microscopic vacuoles within spinal disc cells, representing the future of back pain treatment.

Unlocking Lower Back Pain: How the Tiny Vacuoles in Your Spine Hold the Key to Disc Health

"Could Understanding These Microscopic Structures Revolutionize Treatment for Degenerative Disc Disease?"


Lower back pain (LBP) stands as a global health burden, impacting a significant portion of the population and leading to disability. Intervertebral disc degeneration (IVDD), a condition affecting the discs that cushion the vertebrae, is a major contributor to LBP. Unfortunately, treatments often focus on symptom relief instead of targeting the root causes of IVDD.

The intervertebral disc (IVD) comprises of nucleus pulposus (NP), annulus fibrosus (AF), and cartilaginous endplate (CEP). The nucleus pulposus (NP), the disc's gelatinous core, originates from the embryonic axial notochord. Fascinatingly, cells within the NP, known as notochordal cells, are characterized by unique, large cytoplasmic vacuoles. These vacuoles are not just empty spaces, they are organelles of special functions.

This article delves into the formation, function, and eventual decline of these notochordal vacuoles, exploring their crucial role in maintaining disc health and their potential as a target for regenerative therapies.

AI Search Multiple angles on this topic

How Common Low Back Pain and Disc Changes Are

A 2026 statistics summary reports 619 million cases of low back pain worldwide and says 90% of cases are nonspecific. It also reports disc degeneration on imaging in more than 80% of adults over 50. A separate 2026 review says imaging shows disc degeneration in about a third of pain-free people in their 20s and nearly everyone by age 80, emphasizing that degeneration often causes no symptoms. These figures underscore why imaging findings alone do not establish the source of a person’s pain.

Treating Symptoms While the Disc Remains Degenerated

Current treatments for intervertebral disc degeneration include conservative and surgical approaches, but reviews describe many as focused on relieving low-back-pain symptoms or correcting structural abnormalities. They report that these approaches do not fully restore the degenerated disc or its function. Research into newer, less invasive therapies aims to address the degeneration process itself. The gap between symptom management and disc restoration remains a central limitation of established care.

The Mighty Vacuole: What Do These Structures Do?

Microscopic vacuoles within spinal disc cells, representing the future of back pain treatment.

Notochordal cells (NNPCs) are unique because of their prominent cytoplasmic vacuoles, which can occupy a large portion of the cell's volume. These aren't just random bubbles; they're membrane-bound structures with specialized functions. NNPCs have capabilities, including:

However, in humans, these NNPCs tend to disappear over time, transforming into chondrocyte-like cells. This transformation is linked to the onset of IVDD. Maintaining the health and presence of NNPCs, therefore, emerges as a key strategy in combating disc degeneration.

  • Generating new chondrocyte cells
  • Attracting chondrocytes to the NP
  • Secreting growth factors that rejuvenate cells
  • Stimulating chondrogenesis
  • Suppressing infiltration of nerve or blood vessels
  • Suppressing chondrocyte death in the harsh disc niche
AI Search Multiple angles on this topic

Cell Programming and Other Emerging Research

A 2026 study, “CRISPR activation reveals SOX5/6/9 as key transcriptional regulators directing iPSC-derived cells toward a notochordal lineage,” examines transcriptional regulators involved in guiding induced pluripotent stem-cell-derived cells toward that lineage. Its rationale reflects the reported association between disc degeneration, loss of vacuolated notochordal cells, and fibrotic remodeling of the nucleus pulposus. A separate 2025 study examines how iron deficiency affects disc development and acute injury-induced degeneration; its snippet reports that clinical studies have found more severe lumbar disc degeneration among anemic patients with low back pain than among non-anemic individuals. A 2024 review also covers pain-related neural pathways and microRNA changes associated with cartilage endplate inflammation.

Degeneration Does Not Explain Every Pain Finding

The sources describe disc degeneration as a major contributor to discogenic low back pain, but do not establish it as the explanation for every case of low back pain. One review notes that conventional imaging often fails to reliably identify which structural changes are generating pain. Another describes low back pain as multifaceted and reports that nonspecific cases account for the majority, while age-associated disc degeneration is among the structural causes more relevant to older adults. The notochordal-vacuole review also cautions against treating one developmental pattern as universal: in many non-mammalian vertebrates, the notochord does not necessarily become the nucleus pulposus.

Ultimately, these vacuoles contribute to the mechanical integrity of the spine. As vertebrae develop and compress the notochord, these vacuoles provide the counter-pressure needed to maintain the spine's symmetrical shape.

The Future of Disc Regeneration: Targeting the Vacuole

Notochord vacuolation is vital to embryonic development and is orchestrated by vacuolating signals. Notochord cells are a source of mechanical support that are required for the elongation of growing embryos, and for morphogenesis of the vertebral column. Once the cells are squeezed into the center of the IVD, mechanical stress and an avascular nature of the site can increase exhaustion of vacuoles and promote CNPC transformation. Premature de-vacuolation and degeneration can be better understood, by understanding notochord vacoules.

AI Search Multiple angles on this topic

Expert Views and Better Ways to Characterize Disc Change

A study of lumbar degenerative disc disease set out to examine specialist multidisciplinary stakeholders’ views, noting that the condition is associated with nonspecific low back pain and that effective treatment remains elusive. A 2026 systematic review describes MRI as the standard diagnostic tool but says it gives limited insight into the cellular and molecular changes underlying degeneration. The review presents histological analysis as a complementary way to characterize degenerative processes in human discs. Together, these sources point to an evidence gap between clinical assessment, tissue-level change, and effective treatment.

A Multifactorial Condition With Unmet Treatment Needs

A 2023 review reports that most current therapies for intervertebral disc degeneration focus on low-back-pain symptoms rather than the underlying cause or the disc’s mechanical function. It says conservative and surgical treatments generally do not restore the deteriorated disc. A 2025 narrative review describes degenerative disc disease as multifactorial, involving genetic, mechanical, metabolic, and environmental factors that progressively impair disc structure and function. This complexity helps explain why symptom-focused care and structural correction may leave the underlying degeneration unresolved.

Given the active and versatile role of notochord vacuoles in both embryonic notochord cells and postnatal NNPCs, preservation of vaculoating signals could slow down IVD degeneration.

However, to understand how mammalian vertebral collumns are formed more research is required. This will help validate signaling networks and biological functions of notochord vacuolation.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.18632/oncotarget.18101, Alternate LINK

Title: Formation, Function, And Exhaustion Of Notochordal Cytoplasmic Vacuoles Within Intervertebral Disc: Current Understanding And Speculation

Subject: Oncology

Journal: Oncotarget

Publisher: Impact Journals, LLC

Authors: Feng Wang, Zeng-Xin Gao, Feng Cai, Arjun Sinkemani, Zhi-Yang Xie, Rui Shi, Ji-Nan Wei, Xiao-Tao Wu

Published: 2017-05-23

Everything You Need To Know

1

What is the intervertebral disc and why is it important?

The intervertebral disc (IVD), which is composed of the nucleus pulposus (NP), annulus fibrosus (AF), and cartilaginous endplate (CEP), is a critical structure in the spine. The nucleus pulposus (NP), the core of the IVD, originates from the embryonic axial notochord. It contains unique cells called notochordal cells. These cells are crucial for spinal health, acting as the foundation of the spine.

2

What is the role of vacuoles in the notochordal cells?

Notochordal cells (NNPCs) contain cytoplasmic vacuoles that perform vital functions. These structures generate new chondrocyte cells, attract chondrocytes to the nucleus pulposus, secrete growth factors that rejuvenate cells, stimulate chondrogenesis, suppress the infiltration of nerve or blood vessels, and suppress chondrocyte death. Ultimately, these vacuoles contribute to the mechanical integrity of the spine, which is critical for maintaining spinal health and shape.

3

How are notochordal cells and their vacuoles related to disc degeneration?

Degenerative disc disease (IVDD) is a major contributor to lower back pain. The notochordal cells (NNPCs) which contain vacuoles, naturally diminish over time, transforming into chondrocyte-like cells. This transformation is associated with the onset of IVDD, highlighting the importance of maintaining these NNPCs and their vacuoles for disc health. The premature degeneration of these structures is a major risk factor for IVDD and subsequent lower back pain.

4

What is the significance of the vacuole in spinal health?

The vacuoles in notochordal cells are vital to the health of the spine. These vacuoles provide the mechanical support that is needed for the development of the vertebral column. The vacuoles also help maintain the spine's symmetrical shape by providing counter-pressure as vertebrae develop and compress the notochord. Premature de-vacuolation leads to degeneration, which is a key factor in IVDD.

5

How can targeting vacuoles lead to new treatments?

Research suggests targeting the vacuoles of notochordal cells for regenerative therapies. The article suggests that understanding how to maintain or restore these vacuoles could lead to innovative treatments for degenerative disc disease. This approach focuses on addressing the root causes of IVDD rather than just symptom relief, and thus could potentially revolutionize the treatment of lower back pain.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.